KURA
Price
$9.14
Change
-$0.22 (-2.35%)
Updated
Jan 15, 11:45 AM (EDT)
Capitalization
814.48M
47 days until earnings call
Intraday BUY SELL Signals
STOK
Price
$31.56
Change
+$0.59 (+1.91%)
Updated
Jan 15, 12:11 PM (EDT)
Capitalization
1.77B
55 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

KURA vs STOK

Header iconKURA vs STOK Comparison
Open Charts KURA vs STOKBanner chart's image
Kura Oncology
Price$9.14
Change-$0.22 (-2.35%)
Volume$400
Capitalization814.48M
Stoke Therapeutics
Price$31.56
Change+$0.59 (+1.91%)
Volume$201
Capitalization1.77B
KURA vs STOK Comparison Chart in %
KURA
Daily Signal:
Gain/Loss:
STOK
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
KURA vs. STOK commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KURA is a Hold and STOK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (KURA: $9.36 vs. STOK: $30.97)
Brand notoriety: KURA and STOK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KURA: 51% vs. STOK: 63%
Market capitalization -- KURA: $814.48M vs. STOK: $1.77B
KURA [@Biotechnology] is valued at $814.48M. STOK’s [@Biotechnology] market capitalization is $1.77B. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KURA’s FA Score shows that 1 FA rating(s) are green whileSTOK’s FA Score has 1 green FA rating(s).

  • KURA’s FA Score: 1 green, 4 red.
  • STOK’s FA Score: 1 green, 4 red.
According to our system of comparison, STOK is a better buy in the long-term than KURA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KURA’s TA Score shows that 3 TA indicator(s) are bullish while STOK’s TA Score has 4 bullish TA indicator(s).

  • KURA’s TA Score: 3 bullish, 6 bearish.
  • STOK’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, STOK is a better buy in the short-term than KURA.

Price Growth

KURA (@Biotechnology) experienced а -6.12% price change this week, while STOK (@Biotechnology) price change was -11.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.31%. For the same industry, the average monthly price growth was +3.20%, and the average quarterly price growth was +43.69%.

Reported Earning Dates

KURA is expected to report earnings on Mar 03, 2026.

STOK is expected to report earnings on Mar 11, 2026.

Industries' Descriptions

@Biotechnology (+0.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
STOK($1.77B) has a higher market cap than KURA($814M). STOK YTD gains are higher at: -2.426 vs. KURA (-9.913). STOK has higher annual earnings (EBITDA): 29.1M vs. KURA (-212.24M). KURA has more cash in the bank: 550M vs. STOK (248M). STOK has less debt than KURA: STOK (2.91M) vs KURA (19.5M). STOK has higher revenues than KURA: STOK (206M) vs KURA (104M).
KURASTOKKURA / STOK
Capitalization814M1.77B46%
EBITDA-212.24M29.1M-729%
Gain YTD-9.913-2.426409%
P/E RatioN/A45.54-
Revenue104M206M50%
Total Cash550M248M222%
Total Debt19.5M2.91M671%
FUNDAMENTALS RATINGS
KURA vs STOK: Fundamental Ratings
KURA
STOK
OUTLOOK RATING
1..100
5365
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
81
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9851
PRICE GROWTH RATING
1..100
5336
P/E GROWTH RATING
1..100
1004
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KURA's Valuation (28) in the Biotechnology industry is somewhat better than the same rating for STOK (81) in the null industry. This means that KURA’s stock grew somewhat faster than STOK’s over the last 12 months.

KURA's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as STOK (100) in the null industry. This means that KURA’s stock grew similarly to STOK’s over the last 12 months.

STOK's SMR Rating (51) in the null industry is somewhat better than the same rating for KURA (98) in the Biotechnology industry. This means that STOK’s stock grew somewhat faster than KURA’s over the last 12 months.

STOK's Price Growth Rating (36) in the null industry is in the same range as KURA (53) in the Biotechnology industry. This means that STOK’s stock grew similarly to KURA’s over the last 12 months.

STOK's P/E Growth Rating (4) in the null industry is significantly better than the same rating for KURA (100) in the Biotechnology industry. This means that STOK’s stock grew significantly faster than KURA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KURASTOK
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
89%
Momentum
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
84%
MACD
ODDS (%)
Bearish Trend 7 days ago
77%
Bearish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
85%
Declines
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
72%
Bullish Trend 1 day ago
75%
Aroon
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
KURA
Daily Signal:
Gain/Loss:
STOK
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PNRCX58.580.87
+1.51%
PGIM Jennison Natural Resources C
SPMPX6.280.05
+0.80%
Invesco SteelPath MLP Alpha Plus R5
HILSX24.610.17
+0.70%
Hartford International Value R4
STSVX15.270.09
+0.59%
BNY Mellon Sm Cp Val I
MERFX17.300.02
+0.12%
The Merger Fund A

KURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KURA has been loosely correlated with XNCR. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if KURA jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KURA
1D Price
Change %
KURA100%
+1.63%
XNCR - KURA
59%
Loosely correlated
+3.66%
CLDX - KURA
56%
Loosely correlated
+1.58%
NRIX - KURA
55%
Loosely correlated
+0.58%
VYGR - KURA
55%
Loosely correlated
+2.74%
IMNM - KURA
53%
Loosely correlated
+3.08%
More

STOK and

Correlation & Price change

A.I.dvisor indicates that over the last year, STOK has been loosely correlated with QTTB. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if STOK jumps, then QTTB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STOK
1D Price
Change %
STOK100%
+1.28%
QTTB - STOK
49%
Loosely correlated
+6.82%
NGNE - STOK
46%
Loosely correlated
+10.91%
BCYC - STOK
45%
Loosely correlated
+2.00%
KURA - STOK
44%
Loosely correlated
+1.63%
RGNX - STOK
43%
Loosely correlated
-0.66%
More